UnknownPhase 2NCT02233049

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication

Studying Diffuse intrinsic pontine glioma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Principal Investigator
Jacques GRILL, MD, PhD
Gustave Roussy, Cancer Campus, Grand Paris
Intervention
Erlotinib(drug)
Enrollment
250 enrolled
Eligibility
25 years · All sexes
Timeline
2014 – 2018

Study locations (1)

Collaborators

Innovative Therapies For Children with Cancer Consortium

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02233049 on ClinicalTrials.gov

Other trials for Diffuse intrinsic pontine glioma

Additional recruiting or active studies for the same condition.

See all trials for Diffuse intrinsic pontine glioma →

← Back to all trials